|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/16 | (2006.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Number of the document | 1888040 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06759225.3 |
| Date of filing the European patent application | 2006-05-08 | |
| (97) | Date of publication of the European application | 2008-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2010-08-18 |
| (46) | Date of publication of the claims translation | 2010-12-27 |
| (86) | Number | PCT/US2006/017558 |
| Date | 2006-05-08 |
| (87) | Number | WO 2006/121941 |
| Date | 2006-11-16 |
| (30) | Number | Date | Country code |
| 679607 P | 2005-05-10 | US |
| (72) |
VASANTHAVADA, Madhav, US
LAKSHMAN, Jay Parthiban, US
TONG, Wei-Qin, US
SERAJUDDIN, Abu T.M., US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos, apimančios imatinibą ir atpalaidavimo stabdiklį |
| PHARMACEUTICAL COMPOSITIONS COMPRISING IMATINIB AND A RELEASE RETARDANT |
| Payment date | Validity (years) | Amount | |
| 2016-04-19 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-05-08 |